These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26410808)

  • 81. Preparation and pharmacokinetics of bifunctional epirubicin-loaded micelles.
    Pan Q; Zhang J; Li X; Han X; Zou Q; Zhang P; Luo Y; Jin Y
    Pharmazie; 2019 Oct; 74(10):577-582. PubMed ID: 31685080
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
    Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
    Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce(6) conjugates in a human ovarian carcinoma.
    Tijerina M; Kopecková P; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):269-73. PubMed ID: 11489506
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.
    Malugin A; Kopecková P; Kopecek J
    Mol Pharm; 2006; 3(3):351-61. PubMed ID: 16749867
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.
    Sadekar S; Ray A; Janàt-Amsbury M; Peterson CM; Ghandehari H
    Biomacromolecules; 2011 Jan; 12(1):88-96. PubMed ID: 21128624
    [TBL] [Abstract][Full Text] [Related]  

  • 87. HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.
    Ding L; Gu W; Zhang Y; Yue S; Sun H; Cornelissen JJLM; Zhong Z
    Biomacromolecules; 2019 Oct; 20(10):3855-3863. PubMed ID: 31513391
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.
    Lu CT; Zhao YZ; Wu Y; Tian XQ; Li WF; Huang PT; Li XK; Sun CZ; Zhang L
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):343-8. PubMed ID: 20978763
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
    Li L; Yang Q; Zhou Z; Zhong J; Huang Y
    Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics.
    Lin GY; Lv HF; Lu CT; Chen LJ; Lin M; Zhang M; Zhao YZ; Su ZX; Shen XT; Jiang X; Jin RR; Li X
    J Microencapsul; 2013; 30(6):538-45. PubMed ID: 23489016
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[N-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced MRI.
    Wang Y; Ye F; Jeong EK; Sun Y; Parker DL; Lu ZR
    Pharm Res; 2007 Jun; 24(6):1208-16. PubMed ID: 17387601
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
    Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
    Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
    Gianasi E; Wasil M; Evagorou EG; Keddle A; Wilson G; Duncan R
    Eur J Cancer; 1999 Jun; 35(6):994-1002. PubMed ID: 10533484
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma.
    Somjen D; Katzburg S; Nevo N; Gayer B; Hodge RP; Renevey MD; Kalchenko V; Meshorer A; Stern N; Kohen F
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):144-9. PubMed ID: 18482833
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo.
    Yazdian-Robati R; Ramezani M; Jalalian SH; Abnous K; Taghdisi SM
    Pharm Res; 2016 Sep; 33(9):2289-97. PubMed ID: 27283831
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
    Demoy M; Minko T; Kopecková P; Kopecek J
    J Control Release; 2000 Oct; 69(1):185-96. PubMed ID: 11018556
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
    Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
    Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
    [TBL] [Abstract][Full Text] [Related]  

  • 98. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
    Chytil P; Koziolová E; Etrych T; Ulbrich K
    Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.
    Etrych T; Tsukigawa K; Nakamura H; Chytil P; Fang J; Ulbrich K; Otagiri M; Maeda H
    Eur J Pharm Sci; 2017 Aug; 106():10-19. PubMed ID: 28528285
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
    Lomkova EA; Chytil P; Janoušková O; Mueller T; Lucas H; Filippov SK; Trhlíková O; Aleshunin PA; Skorik YA; Ulbrich K; Etrych T
    Biomacromolecules; 2016 Nov; 17(11):3493-3507. PubMed ID: 27636143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.